FE002-Cart

Asset

Allogeneic chondroprogenitor spheroids engineered to promote functional chondrogenesis and repair cartilage defects.

Stage
Preclinical
Modality
Cell therapy
Target
Not known
1
Indication
0
Trials
1
Developer

Indications

1
  • Knee chondral defects

    Preclinical, doi.org, 20 Aug 2026

In the full profile

  • Owner and partners1
  • Aging relevance1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets